Founder first
Just In
Brands
Resources
Events
Peptris is using AI to find drug candidates to shorten the time it takes for laboratory-validation
The Bengaluru-based company builds models that generate molecules and predict how they will behave, and has licensed its lead candidate to a US developer.
TL;DRAI
Peptris raised $7.7M (Series A, Feb 2026) for AI drug discovery; lead asset PEPR-124 is Phase 2-ready for Duchenne dystrophy. Signal for tech leads: AI-driven discovery is Indian biotech's cost-effective route vs. Western labs, reshaping pharma-AI strategy.
693 words~3 min read
